Here's the live share price of MPS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| MPS Pharma | 0 | 0 | 4.85 | -5.98 | -37.32 | -7.70 | 11.36 |
| Sun Pharmaceutical Industries | 1.96 | 12.84 | 9.86 | 5.49 | 8.79 | 26.67 | 21.76 |
| Divi's Laboratories | 4.16 | 10.16 | 9.95 | 7.22 | 5.10 | 30.72 | 11.37 |
| Torrent Pharmaceuticals | 1.76 | 6.42 | 5.56 | 19.50 | 34.95 | 38.89 | 26.49 |
| Cipla | 9.13 | 14.74 | 6.09 | -7.62 | -5.48 | 15.46 | 9.30 |
| Dr. Reddy's Laboratories | 5.03 | 8.25 | 4.24 | 6.71 | 9.45 | 14.97 | 4.96 |
| Lupin | 1.80 | -1.81 | 2.61 | 12.91 | 12.70 | 43.47 | 13.62 |
| Zydus Lifesciences | 9.48 | 8.82 | 12.93 | 9.52 | 11.80 | 27.27 | 10.63 |
| Mankind Pharma | 4.21 | 15.58 | 21.59 | 11.44 | -3.23 | 23.01 | 11.71 |
| Aurobindo Pharma | 1.80 | 10.80 | 28.89 | 22.91 | 25.65 | 36.99 | 8.29 |
| Laurus Labs | 6.23 | 19.40 | 32.09 | 36.60 | 121.72 | 62.82 | 22.64 |
| Biocon | 6.93 | 19.94 | 12.51 | 4.92 | 25.90 | 21.16 | 2.16 |
| Glenmark Pharmaceuticals | 6.85 | 8.09 | 19.30 | 30.96 | 67.63 | 56.88 | 31.43 |
| Alkem Laboratories | -0.59 | -2.94 | 1.76 | -4.61 | 2.76 | 18.43 | 12.99 |
| Abbott India | 3.50 | 8.84 | 5.50 | -5.88 | -9.27 | 10.06 | 11.66 |
| Anthem Biosciences | -2.04 | 8.33 | 12.74 | 21.94 | 7.35 | 2.39 | 1.43 |
| Ipca Laboratories | 9.27 | 12.50 | 12.80 | 14.25 | 14.95 | 34.77 | 8.65 |
| Ajanta Pharma | 5.55 | 17.38 | 10.25 | 29.67 | 23.96 | 35.93 | 20.13 |
| GlaxoSmithKline Pharmaceuticals | -2.36 | -1.72 | -7.03 | -5.09 | -15.24 | 22.87 | 10.07 |
| Gland Pharma | 20.12 | 25.32 | 22.46 | 26.92 | 51.52 | 28.06 | -7.56 |
Source: Dion Global
Over the last one year, MPS Pharma has declined 37.32% compared to peers like Sun Pharmaceutical Industries (8.79%), Divi's Laboratories (5.10%), Torrent Pharmaceuticals (34.95%). From a 5 year perspective, MPS Pharma has underperformed peers relative to Sun Pharmaceutical Industries (21.76%) and Divi's Laboratories (11.37%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1.7 | 1.71 |
| 10 | 1.69 | 1.72 |
| 20 | 1.76 | 1.81 |
| 50 | 2.22 | 2.21 |
| 100 | 2.97 | 2.49 |
| 200 | 2.47 | 2.42 |
Source: Dion Global
In the latest quarter, MPS Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.58%, FII holding unchanged at 0.00%, and public shareholding unchanged at 63.53% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| May 18, 2026, 09:35 PM IST IST | MPS Pharma - Board Meeting Intimation for Notice Of Board Meeting To Consider The Audited Financial Results Of The Company Fo |
| Apr 19, 2026, 08:18 PM IST IST | MPS Pharma - Confirmation On Non Applicability Of The Criteria Specified Under SEBI Circular No. SEBI/HO/DDHS/P/CIR/2021/613 |
| Apr 13, 2026, 10:36 PM IST IST | MPS Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 13, 2026, 10:19 PM IST IST | MPS Pharma - Statement Of Investor Complaints For The Quarter And Year Ended 31St March, 2026 |
| Apr 13, 2026, 10:18 PM IST IST | MPS Pharma - Statement Of Investor Complaints For The Quarter And Year Ended 31St March, 2026 |
Source: Dion Global
MPS Pharma Ltd. is a Public Limited Listed company incorporated on 09/09/1994 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74899HR1994PLC038300 and registration number is 038300. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 19.11 Cr. for the Year ended 31/03/2025.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for MPS Pharma is ₹1.73 as on May 11, 2026.
The MPS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of MPS Pharma is ₹3.31 Cr as on May 11, 2026.
Today’s highest and lowest price of MPS Pharma are ₹1.73 and ₹1.73.
The 52-week high/low is the highest and lowest price at which MPS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of MPS Pharma is ₹3.01 and 52-week low of MPS Pharma is ₹1.57 as on May 11, 2026.
The MPS Pharma has shown returns of 0.0% over the past day, 0.0% for the past month, 4.85% over 3 months, -37.32% over 1 year, -7.7% across 3 years, and 11.36% over 5 years.
P/E ratio of and PB ratio of MPS Pharma are -3.52 and 7.78 on May 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global